Spire Wealth Management’s BioVie BIVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-104
Closed -$971 2372
2025
Q2
$971 Sell
104
-1
-1% -$10 ﹤0.01% 2286
2025
Q1
$1.03K Buy
105
+80
+320% +$1.28K ﹤0.01% 2383
2024
Q4
$500 Buy
+25
New +$603 ﹤0.01% 2440
2024
Q3
Sell
-15
Closed -$601 2171
2024
Q2
$601 Hold
15
﹤0.01% 2178
2024
Q1
$793 Hold
15
﹤0.01% 2238
2023
Q4
$1.88K Buy
15
+5
+50% +$1.5K ﹤0.01% 2155
2023
Q3
$3.41K Buy
10
+7
+233% +$2.74K ﹤0.01% 2025
2023
Q2
$1.29K Hold
3
﹤0.01% 2264
2023
Q1
$2.42K Hold
3
﹤0.01% 2223
2022
Q4
$2K Buy
+3
New +$1.62K ﹤0.01% 2016

Other funds holding BIVI

Spire Wealth Management's BIVI Position: Q3 2025 in Review

Spire Wealth Management sold out of BioVie (BIVI) in Q3 2025, closing a stake of 104 shares — an estimated $971 sold.

Spire Wealth Management first reported a position in BIVI in Q4 2022 and held it in 10 quarters. The position peaked at $3.41K in Q3 2023. 32 funds tracked by Wall St. Rank hold BIVI as of Q3 2025.

  • Spire Wealth Management reported no remaining BioVie position as of Q3 2025 after selling out during the quarter.
  • Spire Wealth Management sold 104 BioVie shares in Q3 2025, an estimated $971.
  • Spire Wealth Management first reported a position in BioVie in Q4 2022 and held it in 10 quarters.
  • Spire Wealth Management's BioVie position peaked at $3.41K in Q3 2023.
  • 32 funds tracked by Wall St. Rank held BioVie as of Q3 2025.

Based on Spire Wealth Management's 13F filing for Q3 2025, filed 23 Oct 2025.